The largest insider buy on today’s list comes in a Form 4 filing by Bryant R. Riley, chairman and CEO of B. Riley Financial $RILY.
Riley reported a purchase of $2.5 million worth of RILY stock.
Expert technical analysis of financial markets by JC Parets
by David
The largest insider buy on today’s list comes in a Form 4 filing by Bryant R. Riley, chairman and CEO of B. Riley Financial $RILY.
Riley reported a purchase of $2.5 million worth of RILY stock.
by David
From the Desk of Kimmy Sokoloff
Another gap lower for the indices this morning. I’ll be watching to see if the $SPX can hold 3,861 or so.
I was looking for a gap down. Now we’ll see if we can get a bounce.
by JC
With the major indexes below overhead supply, you’re seeing the choppy action.
There are stocks continuing to do very well, like Homebuilders for example. And there are some stocks really struggling, like U.S. Banks.
But in the aggregate, at the index level, you’re seeing the grind. [Read more…]
by David
From the Desk of Kimmy Sokoloff
The market opened lower and continued on that path all day.
It was a tough day, and I tried to manage risk.
The $SPX hit some support at 3,887. The next level down is 3,867.
by JC
Regardless of whether the majority of stocks in the market are going up or down, there seems to always be a group that just wants to keep on falling in price.
They can’t help themselves.
Investors just hate them.
And with that hatred, of course, comes opportunity.
Here’s this week’s shit list: [Read more…]
From the Desk of Steve Strazza @Sstrazza and Alfonso Depablos @AlfCharts
We’re still picking our spots selectively when it comes to long ideas on our Inside Scoop list.
However, every now and then, some secular leaders pop up on our scan, offering us nice entries and favorable risk-reward ratios.
We’re always looking for ways to gain exposure to these outperformers.
Today, we have two industry bellwethers and household names that recently broke out to new highs relative to the broader market.
Let’s take a look at these leaders now.
by David
The largest insider buy on today’s list comes in a Form 4 filing by the early stage life sciences investment firm Atlas Venture.
The venture capital fund now owns a total stake in Dyne Therapeutics $DYN of more than 17%.
by David
From the Desk of Kimmy Sokoloff
The market is continuing yesterday’s slide after Fed Chair Powell’s speech.
For today, I’m watching the 21-day moving average on $SPY at 396.40. We’re slightly below it.